Skip to main content
HR 2467 104th Congress House Commerce Drug industry Drugs Government Operations and Politics Government paperwork Health Intellectual property Patents

To grant certain patent rights for certain nonsteroidal anti-inflammatory drugs for a 2-year period.

Introduced: October 11, 1995 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 104th Congress ended
It never became law before the 104th Congress (1995–1996) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 6, 1995
Referred to the Subcommittee on Courts and Intellectual Property.
Oct 13, 1995
Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.
Oct 11, 1995
Referred to the Committee on the Judiciary, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 11, 1995
Sponsor introductory remarks on measure. (CR E1917)
Oct 11, 1995
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Entitles the owner of the right to market a nonsteroidal anti-inflammatory drug that contains a previously patented active agent, that has been reviewed by the Food and Drug Administration (FDA) for more than 120 months as a new drug application, and that was approved as safe and effective by the FDA on October 29, 1992, to exclude others from making, using, offering for sale, selling, or importing into the United States such active agent for two years beginning October 29, 1997.

Applies the prohibition on infringement of patents to such entitlement. Prohibits submission of an application under the Federal Food, Drug, and Cosmetic Act for introduction into interstate commerce of a drug claimed in a patent, or the use of which is claimed in a patent, before the expiration of such entitlement.

What's happening now November 6, 1995

Referred to the Subcommittee on Courts and Intellectual Property.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 1
All 1 Democratic 1
D
Durbin, Richard J.
Illinois · Oct 18, 1995
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2467: To grant certain patent rights for certain nonsteroidal anti-inflammatory drugs for a 2-year period.. 104th Congress. Open America. https://openamerica.io/bill/104-HR-2467/
MLA
"H.R. 2467: To grant certain patent rights for certain nonsteroidal anti-inflammatory drugs for a 2-year period.." 104th Congress, 2026, Open America, https://openamerica.io/bill/104-HR-2467/.
Bluebook (legal)
H.R. 2467, 104th Cong. (2026), https://openamerica.io/bill/104-HR-2467/.
Markdown link
[H.R. 2467: To grant certain patent rights for certain nonsteroidal anti-inflammatory drugs for a 2-year period.](https://openamerica.io/bill/104-HR-2467/)
Report a problem